Risk of malignancy associated with biologic therapy and methotrexate (MTX) in the Psoriasis Longitudinal Assessment and Registry (PSOLAR) Fiorentino, D., Ho, V., Lebwohl, M., Leite, L., Hopkins, L., Galindo, C., Langholff, W., Srivastava, B., Langley, R. MOSBY-ELSEVIER. 2017: AB221

View details for Web of Science ID 000403369302096